Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic
-
- STATUS
- Recruiting
-
- participants needed
- 200
-
- sponsor
- Centre for Addiction and Mental Health
Summary
The current study aims to assess the feasibility, acceptance and clinical outcomes of a practical high-dose aiTBS protocol, including tapering treatments and symptom-based relapse prevention treatments, in patients with unipolar depression previously responsive to ECT and patients needing urgent treatment due to symptom severity during the COVID-19 pandemic.
Details
| Condition | Major depression, Endogenous depression |
|---|---|
| Age | 18years - 100years |
| Treatment | MagPro X100 Stimulator, B70 Fluid-Cooled Coil |
| Clinical Study Identifier | NCT04384965 |
| Sponsor | Centre for Addiction and Mental Health |
| Last Modified on | 16 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.